Mengshan Cui analyzes economic issues arising in healthcare, life sciences, and consumer fraud and product liability matters. Dr. Cui has worked on health insurance reimbursement and regulation issues, including disputes involving the No Surprises Act. She also analyzes allegations of public nuisance and false advertising. In commercial disputes and general damages matters, Dr. Cui has conducted econometric analyses to assess how alleged misconduct, fraud, or defects affected market outcomes. She has experience assessing damages across a range of contexts.
Dr. Cui leads teams to develop robust, empirical analyses that leverage academic and market research. Her experience includes matters in U.S. state and federal courts, as well as arbitration proceedings.
Healthcare
- Consulting on out-of-network payment disputes for emergency room services
- Evaluating reimbursement rates under the Fair Market Value construct
- Evaluating economic issues related to the fair market value of insurance payments under the No Surprises Act
- Analyzing price negotiation dynamics between insurers and providers and economic issues related to health insurance regulation
Life sciences
- Consulting on economic issues related to preferred pharmacy networks and pharmaceutical product marketing
- Evaluating failure-to-warn allegations in matters involving infant formula products
Consumer fraud and product liability
- Applying academic research, content analysis, and marketing principles to assess false advertising allegations
- Assessing how product, advertisement, and website design impact consumer behavior, including in matters involving alleged “dark patterns”